Marinomed Biotech AG (WBO:MARI) Days Payable

: 53.80 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

Marinomed Biotech AG's average Accounts Payable for the three months ended in Dec. 2023 was €1.06 Mil. Marinomed Biotech AG's Cost of Goods Sold for the three months ended in Dec. 2023 was €1.80 Mil. Hence, Marinomed Biotech AG's Days Payable for the three months ended in Dec. 2023 was 53.80.

The historical rank and industry rank for Marinomed Biotech AG's Days Payable or its related term are showing as below:

WBO:MARI' s Days Payable Range Over the Past 10 Years
Min: 42.37 Med: 62.89 Max: 103.52
Current: 42.37

During the past 9 years, Marinomed Biotech AG's highest Days Payable was 103.52. The lowest was 42.37. And the median was 62.89.

WBO:MARI's Days Payable is ranked worse than
77.59% of 714 companies
in the Biotechnology industry
Industry Median: 151.205 vs WBO:MARI: 42.37

Marinomed Biotech AG's Days Payable increased from Dec. 2022 (35.75) to Dec. 2023 (53.80). It may suggest that Marinomed Biotech AG delayed paying its suppliers.

Marinomed Biotech AG Days Payable Historical Data

The historical data trend for Marinomed Biotech AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

82.71

62.00

71.02

62.89

60.92

Marinomed Biotech AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															35.75	25.81	40.40	38.39	53.80

Competitive Comparison

For the Biotechnology subindustry, Marinomed Biotech AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinomed Biotech AG Days Payable Distribution

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's Days Payable distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's Days Payable falls into.

Marinomed Biotech AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Marinomed Biotech AG's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.153	+	1.531)	/	2 )	/	8.041	*	365
=	1.342					/	8.041	*	365
=	60.92

Marinomed Biotech AG's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.589	+	1.531)	/	2 )	/	1.798	*	365 / 4
=	1.06					/	1.798	*	365 / 4
=	53.80

Marinomed Biotech AG Days Payable Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG (WBO:MARI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (WBO:MARI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

93Z:Germany

Address

Hovengasse 25, Korneuburg, AUT, 2100

Website

https://www.marinomed.com

Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (WBO:MARI) Headlines

No Headlines